COURSE DETAILS
It is with great pleasure that we announce that the Oncology Academy’s first event will take place on Friday 8 – Saturday 9 September 2023 and will be held at the Lagoas Park Hotel, Portugal.
This 2-day meeting will bring together mid-level oncologists who specialise in breast and prostate cancer to experience a range of informative and interactive sessions, including plenary and panel discussions, hot topic breakout sessions, case study presentations and workshops.
Agenda
Please click for further details on the agenda (note that the agenda is subject to change).
Agenda
Please see below for the detailed agenda (note that the agenda is subject to change).
Pushing the Boundaries in the Management and Treatment of Breast and Prostate Cancer
Co-chairs: Matti Aapro and Ken Hermann
Day 1: Friday 8 September
| Time (CST) | Session | Speakers(s)/Moderator(s) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 09:00–09:20 | Welcome and Introduction | Co-chairs | |||||||
| 09:20–09:40 | Precision Medicine in the Oncology Clinic: Practical Solutions | Barbara Pistilli (France) | |||||||
| 09:40–10:00 | Immunoconjugates for Cancer Therapy: Innovations and Opportunities | Speaker TBC | |||||||
| 10:00–10:10 | Panel Discussion and Audience Q&A | Barbara Pistilli (France) Speaker TBC Co-Chairs |
|||||||
| 10:10–10:30 | Coffee break | ||||||||
| 10:30–10:55 | Parallel Speciality Plenary Latest Treatment Guidelines and Best Practice in the Management of Patients with Metastatic Breast Cancer |
Shani Paluch-Shimon (Israel) | |||||||
| Parallel Speciality Plenary Latest Treatment Guidelines and Best Practice in the Management of Patients with Prostate Cancer |
Jochen Walz (France) | ||||||||
| 10:55–11:00 | Return to main plenary room | ||||||||
| 11:00–11:25 | Radiopharmaceutical Therapy: Effective Targeted Approach to Treating Breast and Prostate Cancer | Ken Herrmann (Germany) | |||||||
| 11:25–11:40 | Panel Discussion and Audience Q&A | Shani Paluch-Shimon (Israel) Jochen Walz (France) Ken Herrmann (Germany) |
|||||||
| 11:40–12:05 | Parallel Speciality Plenary Hot topic 1: Latest Advances in Metastatic Breast Cancer Research |
Barbara Pistilli (France) | |||||||
| Parallel Speciality Plenary Hot topic 2: Latest Advances in Metastatic Prostate Cancer Research |
Giulia Baciarello (Italy) | ||||||||
| 12:05–13:00 | Lunch | ||||||||
| 13:00–14:30 Breakout speciality workshops |
Shared Learning Case Studies Workshop – Best Practice Sharing | Giulia Baciarello (Italy) Matti Aapro (Switzerland) |
|||||||
| 14:30–14:50 | Coffee break | ||||||||
| 14:50–15:50 | Key Considerations for Effective Physician–Patient Communication in Cancer Care Workshop | Luzia Travado (Portugal) | |||||||
| 15:50–16:00 | Summary and Close | Co-Chairs | |||||||
| 19:00–22:00 | Dinner | ||||||||
Day 2: Saturday 9 September
| Time (CST) | Session | Speakers(s)/Moderator(s) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 08:00–08:55 | Meet the Faculty Breakfast Session | All Faculty | |||||||
| 08:55–09:00 | Convene in main plenary room | ||||||||
| 09:00–09:10 | Recap of Day 1 and welcome to Day 2 | Co-Chairs | |||||||
| 09:10–09:40 | Reflections on ASCO 2023: Key Takeaways in Breast and Prostate Cancer | PC: Giulia Baciarello (Italy) BC: Matti Aapro (Switzerland) |
|||||||
| 09:40–10:00 | The Role of Digital Technology and Artificial Intelligence (AI) in Advancing the Detection and Management of Breast and Prostate Cancer | Jean-Jacques Zambrowski (France) | |||||||
| 10:00–10:00 | Collaboration in Cancer Care – Negotiating and Influencing 101 Workshop | Speaker TBC Matti Aapro (Switzerland) Ken Herrmann (Germany) |
|||||||
| 11:00–11:15 | Coffee break | ||||||||
| 11:15–12:15 | Highlighting the Benefits of a Multidisciplinary Team (MDT) Approach in Cancer Care Workshop | Luis Costa (Portugal) | |||||||
| 12:15–13:00 | Lunch | ||||||||
| 13:00–13:25 | Improving Quality of Life (QoL) in Older Patients with Cancer | Jochen Walz (France) | |||||||
| 13:25–14:00 | Financial Burden of Cancer Care: Management Strategies for Oncologists | Jean-Jacques Zambrowski (France) | |||||||
| 14:00–14:15 | Panel Discussion and Audience Q&A | Matti Aapro (Switzerland) Jochen Walz (France) Jean-Jacques Zambrowski (France) |
|||||||
| 14:15–14:45 | Roundtable debate + panel discussion What Cancer Care Will Look Like in 10 Years: 10 Reasons for Optimism |
Co-Chairs Luis Costa (Portugal) Giulia Baciarello (Italy) |
|||||||
| 14:45–15:00 | Meeting Summary and Close | Co-Chairs | |||||||
CME ACCREDITATION
The Oncology Academy 2023: Pushing the Boundaries in the Management and Treatment of Breast and Prostate Cancer, Porto Salvo, Lisbon, Portugal, 08/09/2023-09/09/2023 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 11 European CME credits (ECMEC®s).
Guest speakers for 2023
Dr Diogo Conçalves
Diogo Conçalves is an Anatomic Pathology Specialist at Hospital CUF Descobertas, Lisbon, Portugal. He earned his Integrated Master of Medicine at the School of Medicine of the University of Lisbon, Lisbon. Dr Conçalves went on to complete a general medical residency at the Central Lisbon University Hospital Centre, Lisbon, and an Anatomic Pathology residency at Hospital Garcia de Orta, also in Lisbon.
Dr Etienne Brain
Etienne Brain, MD, is board certificated in medical oncology, and has worked at Institut Curie in Saint-Cloud, France since 1998. Following a fellowship at the Dana Farber Cancer Institute and Boston University, both in Boston, MA, USA in 1996, he obtained a PhD in 2005. He supervised research at Versailles/Saint-Quentin University in Versailles, France in 2010. He received a diploma in Management and Health Economics from Bocconi University in Milan, Italy in 2015.
For more than 20 years, Dr Brain has been very involved in clinical research for breast cancer and cancer in older patients. He has chaired the group GERICO (Unicancer) and the DIALOG intergroup (labelled by the INCa), both of which are dedicated to clinical research on cancer in older persons. Dr Brain has chaired the breast cancer group of the European Organisation for Research and Treatment of Cancer (EORTC), and he has been the EORTC Secretary General since 2021. He is an executive board member of the Breast International Group.
The management of breast cancer in older patients is the key issue addressed by Dr Brain’s work, considering both competitive risks for mortality and frailty in the treatment decision-making process. This is best epitomised by the ASTER 70s study; the largest clinical trial (2000 women aged 70 and older) ever conducted, of which he presented the results at the American Society of Clinical Oncology annual meeting in Chicago in June 2022, after receiving the B.J. Kennedy Geriatric Oncology Award at the same meeting. He also received the Michel Hery Award in geriatric oncology at the Monaco Age Oncology conference 2023.
Professor Luís Costa
Luís Costa, MD, PhD, is Professor of Medicine at the Lisbon School of Medicine, University of Lisbon, Portugal where he coordinates the teaching of oncobiology, which is a new learning unit that aims to teach an understanding of clinical oncology through molecular medicine. He has been head of the Oncology Department at Hospital de Santa Maria in Lisbon since 2005, and was appointed as the director of the Clinical Research Centre at the Lisbon Academic Medical Centre in 2015. Since 2007, Prof. Costa has been the head of the Clinical and Translational Oncology Research Unit at Instituto de Medicina Molecular.
Prof. Costa has been involved in multiple clinical trials in breast cancer and other solid tumours, and his research interests have long centred on the area of bone metastases. In recent years, his research has focused on understanding the molecular mechanisms of tumour progression at metastatic sites using bone metastases as a paradigm.
Prof. Costa also acts as an expert for grant reviews at the European Research Council, Cancer Research UK, the French National Cancer Institute, and the Netherlands Cancer Institute. He is Academic Editor for Plos One, the Journal of Bone Oncology and Annals of Medicine and has published more than 150 peer-reviewed articles and other publications.
Dr Luzia Travado
Luzia Travado, PhD, MSc, ClinPsych, is a clinical psychologist specialising in health psychology and psycho-oncology, with degrees from the University of Lisbon, and a doctorate from the University of Coimbra, both in Portugal. She is currently a clinician and researcher of psycho-oncology at the Champalimaud Clinical Centre of the Champalimaud Foundation, Lisbon.
Dr Travado’s 35-year long career started at Hospital de São José, Central Lisbon University Hospital Centre, where she pioneered health psychology by developing psychosocial programmes for clinical populations including cancer. Dr Travado served as Adviser of the National Cancer Director in Portugal (2007–2011), contributed to the National Cancer Control Programme by introducing psychosocial care for cancer patients, and communication skills training through a national pilot programme. She represented Portugal at the European Partnership on Action Against Cancer (EPAAC, 2009–2019) and led the Psychosocial Oncology Action training strategy.
Dr Travado is an active advocate of psychosocial cancer care at European cancer policy level and participates in various European collaborative projects and European Commission initiatives. She served as President of the International Psycho-Oncology Society, currently President-Emeritus, was Chair of the International Psycho-Oncology Society (IPOS) World Congress of Psycho-Oncology held in Lisbon in 2014 and is currently co-chair of IPOS-2023 in Milan.
Dr Travado has been a researcher on many nationally and internationally funded research projects, including some as principal investigator. In 2022, Dr Travado received the Jimmie Holland Memorial Award in recognition for her important and substantial contribution to the field of psycho-oncology.
Dr Barbara Pistilli
Barbara Pistilli, MD, is Chair of the Breast Cancer Unit at Gustave Roussy, Villejuif, France, since 2021. The clinical activity of the unit includes more than 2000 new patients and 700 inclusions in clinical trials each year.
Since March 2020, Dr Pistilli has been leading a large translational programme focusing on identification of mechanisms of response and resistance to antibody drug conjugates, which include several phase I and II trials based on diverse treatment strategies in patients with metastatic breast and lung cancer, with a large sample collection for exploratory biomarker analysis. The scientific strategy relies on the integration between translational and clinical research groups, where knowledge in biology drives clinical development and patient samples feed translational research.
She also leads academic programmes funded by French Health Minister grants, which are focused on adherence to endocrine therapy and biomarker-driven treatment de-escalation strategies.
Dr Jochen Walz
Jochen Walz is Assistant Professor of Urology and Head of the Department of Urology at the Paoli-Calmettes Institute Cancer Centre, Marseille, France. He also serves as Co-Editor in Chief of the European Urology Open Science journal. Professor Walz’ research interests comprise urology and prostate cancer, more specifically imaging and diagnosis, prediction tools, life expectancy and surgical treatment, as well as minimally invasive surgical techniques. He has authored over 170 articles and has received awards from international, national and regional societies for his research.
Professor Walz is a member of the American Urological Association, the European Association of Urology and the German Society of Urology; he is a faculty member of the European School of Urology, the European Society for Radiotherapy and Oncology and the Société Internationale d'Urologie.
Please see below the preliminary agenda. Please check back for updates to the agenda in due course.
Day 1: Friday 8 September
|
Time (CST) |
Session | |||
|---|---|---|---|---|
|
09:00–09:15 |
Welcome and Introduction |
|||
|
09:15–09:50 |
Precision Medicine in the Oncology Clinic: Practical Solutions |
|||
|
09:50–10:25 |
Immunoconjugates for Cancer Therapy: Innovations and Opportunities |
|||
|
10:25–10:45 |
Coffee break |
|||
|
10:45–11:45 |
Workshop 1: Shared Learning Case Studies – Best Practice Sharing |
|||
|
11:45–12:20 |
Hot topic 1: Latest Advances in Metastatic Breast Cancer Research |
|||
|
Hot topic 2: Latest Advances in Metastatic Prostate Cancer Research |
||||
|
12:20–13:00 |
Latest Treatment Guidelines and Best Practice in the Management of Patients with Metastatic Breast Cancer |
|||
|
Latest Treatment Guidelines and Best Practice in the Management of Patients with Prostate Cancer |
||||
|
13:00–14:00 |
Lunch |
|||
|
14:00–15:00 |
Workshop 2: Key Considerations for Effective Physician-Patient Communication in Cancer Care |
|||
|
15:00–15:30 |
Coffee break |
|||
|
15:30–16:05 |
Radiopharmaceutical therapy (RPT): Effective Targeted Approach to Treating Breast and Prostate Cancer |
|||
|
16:05–16:40 |
Financial Burden of Cancer Care: Management Strategies for Oncologists |
|||
|
16:40–16:45 |
Summary and close |
|||
|
19:00–22:00 |
Dinner |
|||
Day 2: Saturday 9 September
|
Time (CST) |
Session | |||
|---|---|---|---|---|
|
Breakfast |
Meet the Experts Breakfast Session |
|||
|
09:30–09:35 |
Day 2 Welcome |
|||
|
09:35–10:10 |
Reflections on ASCO 2023: Key Takeaways in Breast and Prostate Cancer |
|||
|
10:10–11:10 |
Workshop 3: Collaboration in Cancer Care – Negotiating and Influencing 101 |
|||
|
11:10–11:30 |
Coffee break |
|||
|
11:30–12:30 |
Workshop 4: Highlighting the Benefits of a Multidisciplinary Team (MTD) Approach in Cancer Care |
|||
|
12:30–13:30 |
Lunch |
|||
|
13:30–14:05 |
Improving Quality of Life (QoL) in Older Patients with Cancer |
|||
|
14:05–14:50 |
What Cancer Care Will Look Like in 10 years: 10 Reasons for Optimism |
|||
|
14:50–15:00 |
Meeting summary and close |
|||
Note that the agenda is subject to change.
